Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldenberg

Showing results (531-540 of 968) with videos related to

Pageof 97
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 1, 1987
Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian diseaseJ Blankstein, J Rabinovici, M Goldenberg, et al.
Theranostics|June 28, 2012
Pretargeted molecular imaging and radioimmunotherapyDavid M Goldenberg, Chien-Hsing Chang, Edmund A Rossi, et al.
Cancer Research|October 1, 1988
Reduction of radioantibody-induced myelotoxicity in hamsters by recombinant interleukin-1R D Blumenthal, R M Sharkey, D J Snyder, et al.
Culture, Health & Sexuality|August 4, 2020
Harms of third party criminalisation under end-demand legislation: undermining sex workers' safety and rightsBronwyn McBride, Kate Shannon, Alka Murphy, et al.
Social Sciences (Basel, Switzerland)|October 6, 2023
BARRIERS TO GOVERNMENTAL INCOME SUPPORTS FOR SEX WORKERS DURING COVID-19: RESULTS OF A COMMUNITY-BASED COHORT IN METRO VANCOUVERJennie Pearson, Kate Shannon, Andrea Krüsi, et al.
Molecular Cancer|March 11, 2014
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancerDonglin Liu, Thomas M Cardillo, Yang Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancerRobert M Sharkey, George Hajjar, Dion Yeldell, et al.
International Journal of Oncology|May 5, 2005
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16)David E Modrak, Habibe Karacay, Thomas M Cardillo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancerM Juweid, R M Sharkey, L C Swayne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvestM E Juweid, R D Blumenthal, W Lew, et al.
Pageof 97

Showing results (531-540 of 968) with videos related to

Sort By:
Pageof 97
The Journal of Clinical Endocrinology and Metabolism|December 1, 1987
Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian diseaseJ Blankstein, J Rabinovici, M Goldenberg, et al.
Theranostics|June 28, 2012
Pretargeted molecular imaging and radioimmunotherapyDavid M Goldenberg, Chien-Hsing Chang, Edmund A Rossi, et al.
Cancer Research|October 1, 1988
Reduction of radioantibody-induced myelotoxicity in hamsters by recombinant interleukin-1R D Blumenthal, R M Sharkey, D J Snyder, et al.
Culture, Health & Sexuality|August 4, 2020
Harms of third party criminalisation under end-demand legislation: undermining sex workers' safety and rightsBronwyn McBride, Kate Shannon, Alka Murphy, et al.
Social Sciences (Basel, Switzerland)|October 6, 2023
BARRIERS TO GOVERNMENTAL INCOME SUPPORTS FOR SEX WORKERS DURING COVID-19: RESULTS OF A COMMUNITY-BASED COHORT IN METRO VANCOUVERJennie Pearson, Kate Shannon, Andrea Krüsi, et al.
Molecular Cancer|March 11, 2014
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancerDonglin Liu, Thomas M Cardillo, Yang Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2005
A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancerRobert M Sharkey, George Hajjar, Dion Yeldell, et al.
International Journal of Oncology|May 5, 2005
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16)David E Modrak, Habibe Karacay, Thomas M Cardillo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancerM Juweid, R M Sharkey, L C Swayne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvestM E Juweid, R D Blumenthal, W Lew, et al.
Pageof 97